Comparison analysis between the prediction success and fail groups identified statistically significant differences in age, menopausal status, FSH, tumor size, HG, NG, LN metastasis, PR, HER2, and Ki-67 (Table S3). The gene discussed is ERBB2; the disease is neoplasm.